Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1994
Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism
R van Kuyk, B E Torbett, R J Gulizia, et al.
Oncogene
|
January 15, 2008
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity
M P Tschan, V A Reddy, A Ress, et al.
Blood
|
November 26, 1999
Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis
L Crisa, V Cirulli, K A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 5, 2000
Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells
K L Anderson, H Perkin, C D Surh, et al.
Blood
|
June 20, 1998
Myeloid development is selectively disrupted in PU.1 null mice
K L Anderson, K A Smith, K Conners, et al.
AIDS Research and Human Retroviruses
|
February 1, 1994
Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells
B Reinhardt, B E Torbett, R J Gulizia, et al.
The Journal of Biological Chemistry
|
December 15, 2000
PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45
K L Anderson, S L Nelson, H B Perkin, et al.
Leukemia
|
March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
M Jenal, J Batliner, V A Reddy, et al.
Cellular Immunology
|
May 1, 1993
The expression of CD45RB on antigen-responsive CD4+ lymphocytes: mouse strain polymorphism and different responses to distinct antigens
L C Gahring, D N Ernst, C G Romball, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 1998
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo
T Lee, G S Laco, B E Torbett, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1994
Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism
R van Kuyk, B E Torbett, R J Gulizia, et al.
Oncogene
|
January 15, 2008
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity
M P Tschan, V A Reddy, A Ress, et al.
Blood
|
November 26, 1999
Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis
L Crisa, V Cirulli, K A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 5, 2000
Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells
K L Anderson, H Perkin, C D Surh, et al.
Blood
|
June 20, 1998
Myeloid development is selectively disrupted in PU.1 null mice
K L Anderson, K A Smith, K Conners, et al.
AIDS Research and Human Retroviruses
|
February 1, 1994
Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells
B Reinhardt, B E Torbett, R J Gulizia, et al.
The Journal of Biological Chemistry
|
December 15, 2000
PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45
K L Anderson, S L Nelson, H B Perkin, et al.
Leukemia
|
March 5, 2010
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
M Jenal, J Batliner, V A Reddy, et al.
Cellular Immunology
|
May 1, 1993
The expression of CD45RB on antigen-responsive CD4+ lymphocytes: mouse strain polymorphism and different responses to distinct antigens
L C Gahring, D N Ernst, C G Romball, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 1998
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo
T Lee, G S Laco, B E Torbett, et al.
Page
of 5